Explore BioDuro’s integrated discovery chemistry capabilities, including medicinal, synthetic, peptide, analytical, and computational expertise across small molecules, ADCs, PROTACs, oligonucleotides, and other emerging modalities. Learn how our teams accelerate programs from hit identification through candidate selection and preclinical scale-up.

• 1,300+ chemists across four global research sites supporting a broad range of discovery programs.
• 88,000+ compounds delivered with the capacity to synthesize 6,000 compounds per month.
• Expertise across small molecules, peptides, ADCs, PROTACs, oligonucleotides, and other emerging modalities.
• Advanced discovery capabilities including AI-assisted molecular design, virtual screening, parallel synthesis, and enabling chemistry technologies.
• Integrated Chemistry, Biology, and DMPK teams working collaboratively to accelerate hit-to-lead and lead optimization programs.
• Seamless scale-up support from discovery quantities through preclinical supply with established pathways into Process Chemistry and CMC development.

Download the Discovery Chemistry Engine flyer to explore BioDuro’s capabilities, scientific expertise, and integrated approach to accelerating drug discovery from hit identification through candidate selection and scale-up.